Title : Clinical management strategies for type 2 diabetes.

Pub. Date : 2007 Dec

PMID : 18217246






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 When used in combination with metformin, sulfonylureas, or TZDs, GLP-1 analogs such as exenatide and DPP-IV inhibitors such as sitagliptin reduce A1C, fasting glucose levels, and postprandial glucose levels with few additional adverse events. Glucose dipeptidyl peptidase 4 Homo sapiens
2 When used in combination with metformin, sulfonylureas, or TZDs, GLP-1 analogs such as exenatide and DPP-IV inhibitors such as sitagliptin reduce A1C, fasting glucose levels, and postprandial glucose levels with few additional adverse events. Glucose dipeptidyl peptidase 4 Homo sapiens